DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.

Clinical trial NCT07440290 · RECRUITING

Trial details

NCT number: NCT07440290
Sponsor: Cancer Research UK
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Haematological Malignancy Malignant Neoplasm Lymphoproliferative Disorders Neoplasms by Histologic Type Neoplasms by Site Gastrointestinal Cancer Non-Melanoma Skin Cancer (NMSC)Langerhans Cell Histiocytosis (LCH)Cancer Erdheim-Chester Disease Thyroid Carcinoma, Papillary Ovarian Neoplasms

Start date: 2026-04-01
Primary completion: 2029-10-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.